Delivery Order SPE2DB20D2104-SPE2DB24FV22U

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,104,148 units of the prescription drug clobazam 10 mg tablets. The delivery order has a ceiling value of $3,644.89 and an ultimate completion date of October 16, 2024. The contract is a firm fixed-price Delivery Order, and there was no set-aside designation used. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,820.13 for the supply of 4,565,563,070 units of the prescription drug Clobazam 10 mg tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 26, 2024. The contract is a firm fixed-price delivery order and does not utilize any set-aside designations. AmerisourceBergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,667.79 firm fixed-price delivery order is for the supply of 4,567,039,867 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,955,731 units of the medication clobazam 10 mg tablets. The contract has a ceiling value of $2,145.41 and a period of performance through April 18, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,627.80 firm-fixed-price delivery order is for the supply of 4,567,692,420 units of the pharmaceutical product Clobazam 10 mg tablets. The contract has a period of performance through March 26, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of 4,564,531,043 units of the drug clobazam 10mg tablets, in 100-count packages, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $4,898.40 and is a firm fixed-price delivery order with a completion date of May 8, 2024. The contract is not associated with any set-aside...
This federal contract award, valued at $4,667.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,142,117 units of the medication Clobazam 10 mg tablets. The contract is a Delivery Order with a firm fixed price, and has an ultimate completion date of May 6, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $5,369.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of 4,568,174,760 units of the medication Clobazam 10 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period extending through May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award is for the delivery of 4,565,768,375 units of the pharmaceutical drug clobazam 10 mg tablets, packaged in 100-count bottles. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on September 11, 2024. The contract is a firm-fixed-price delivery order with a ceiling value of $9,129.65 and an ultimate completion date of September 12, 2024. This award is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,676.49 firm fixed-price delivery order is for the supply of 4,566,186,788 tablets of the prescription medication Clobazam 10 mg. The contract has an ultimate completion date of October 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FV22U
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,176,880 units of the drug clobazam 10 mg tablets. The $1,555.93 firm fixed price contract has a completion date of July 18, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 11:02 AM